Biogen, Inc. - Company Profile and SWOT Analysis

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $175	48 Pages	MarketLine	February, 2025	MTLN19882736

Best Price Guarantee
Price	from $175
Length	48 Pages
Publisher	MarketLine
Published Date	February, 2025
SKU	MTLN19882736

Biogen, Inc. - Company Profile and SWOT Analysis

Summary

Biogen, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Biogen, Inc. (Biogen or 'the company') discovers, develops, manufactures and commercializes therapies in the areas of hematology, neurology and immunology. The company develops therapies for multiple sclerosis, neuroimmunology movement disorders, including Parkinson's disease, Alzheimer's disease and dementia, and neuromuscular disorders, including amyotrophic lateral sclerosis and spinal muscular atrophy. It also develops and manufactures biosimilars of advanced biologics. The company markets its products under Flixabi, Benepali, Imraldi, Spinraza, Tecfidera, Avonex, Tysabri, Eylea, Gazyva, Fampyra, Plegridy and Fumaderm brand names. Biogen has business operations in the North America, Asia and Europe. The company is headquartered in Weston, Massachusetts, the US.

Scope

Detailed information on Biogen, Inc. required for business and competitor intelligence needs
A study of the major internal and external factors affecting Biogen, Inc. in the form of a SWOT analysis
An in-depth view of the business model of Biogen, Inc. including a breakdown and examination of key business segments
Intelligence on Biogen, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Biogen, Inc., such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Biogen, Inc. and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess Biogen, Inc. as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Biogen, Inc.'s business structure, strategy and prospects.

Company Snapshot: Biogen, Inc.: Company Overview; Biogen, Inc.: Overview and Key Facts; Biogen, Inc.: Overview; Biogen, Inc.: Key Facts; Biogen, Inc.: Key Employees; Biogen, Inc.: Key Employee Biographies; Biogen, Inc.: Major Products and Services; Biogen, Inc.: Management Statement; Biogen, Inc.: Key Competitors; Biogen, Inc.: Company Analysis; Biogen, Inc.: Business Description; Biogen, Inc.: SWOT Analysis; Biogen, Inc.: SWOT Overview; Biogen, Inc.: Strengths; Biogen, Inc.: Weaknesses; Biogen, Inc.: Opportunities; Biogen, Inc.: Threats; Biogen, Inc.: Corporate Financial Deals Activity; Biogen, Inc.: Financial Deals Overview; Biogen, Inc.: Targets and Partners; Biogen, Inc.: Top Deals 2021 - 2025YTD*; Biogen, Inc.: Advisors; Biogen, Inc.: Top Legal Advisors; Biogen, Inc.: Top Financial Advisors; Biogen, Inc.: Mergers and Acquisitions; Biogen, Inc.: Corporate Venturing; Biogen, Inc.: Capital Raising; Biogen, Inc.: Partnership; Biogen, Inc.: Divestments; Biogen, Inc.: Recent Developments; Biogen, Inc.: News and Events Summary; Biogen, Inc.: Corporate Governance; Biogen, Inc.: Financial Performance; Biogen, Inc.: Market Developments; Biogen, Inc.: Regulatory and Legal Events; Biogen, Inc.: Research & Development; Biogen, Inc.: Strategy and Operations
Appendix: Contact Us; Methodology; About MarketLine
List of Tables: Table 1: Biogen, Inc.: Key Facts; Table 2: Biogen, Inc.: Key Employees; Table 3: Biogen, Inc.: Key Competitors; Table 4: Biogen, Inc.: Deal Activity by Deal Type - Volume (TTM*); Table 5: Biogen, Inc.: Deal Activity by Deal Type - Volume (2021 - YTD*2025); Table 6: Biogen, Inc.: M&A Average Deal Size - Value (US$m); Table 7: Biogen, Inc.: Targets and Partners; Table 8: Biogen, Inc.: Top Deals 2021 - 2025YTD*; Table 9: Biogen, Inc.: Legal Advisor Ranking by Value (US$m); Table 10: Biogen, Inc.: Financial Advisor Ranking by Value (US$m); Table 11: Biogen, Inc.: M&A Volume and Value Trend (2021 - YTD*2025); Table 12: Biogen, Inc.: Corporate Venturing Volume and Value Trend (2021 - YTD*2025); Table 13: Biogen, Inc.: Capital Raising Volume and Value Trend (2021 - YTD*2025); Table 14: Biogen, Inc.: Capital Raising by Deal Type (2021 - YTD*2025); Table 15: Biogen, Inc.: Partnership Volume and Value Trend (2021 - YTD*2025); Table 16: Biogen, Inc.: Partnership Trend by Deal Type (2021 - YTD*2025); Table 17: Biogen, Inc.: Divestments Volume and Value Trend (2021 - YTD*2025); Table 18: Biogen, Inc.: Divestments by Geography (2021 - YTD*2025); Table 19: Biogen, Inc.: News and Events Summary; Table 20: Biogen, Inc.: Corporate Governance; Table 21: Biogen, Inc.: Financial Performance; Table 22: Biogen, Inc.: Market Developments; Table 23: Biogen, Inc.: Regulatory and Legal Events; Table 24: Biogen, Inc.: Research & Development; Table 25: Biogen, Inc.: Strategy and Operations